Developing/tropical countries are becoming preferred travel destinations over previously more popular Western/developed countries. This will lead to an increased risk of infec-
If there is insufficient time before departure, travelers may need to receive multiple simultaneous vaccinations or to follow accelerated vaccination schedules. The former has been investigated for various vaccine combinations and the latter mainly for rabies, hepatitis B, and tick-borne encephalitis vaccines. A mathematical model shows a 25-year efficacy of Western hepatitis A vaccines after its primary course (two doses at 0,6 mo -1 yr), and that even if the second dose is delayed until 6 years, an effective booster response could be obtained. Unfortunately, vaccines marketed in Japan differ from those in Western countries and therefore the Western data could not be applied directly to our situation. In Japan, mefloquine is the only antimalarial drug approved for preventive use. The drug is regarded to produce neuropsychiatric AEs at a higher rate than other antimalarials and is being gradually replaced by atovaquone/proguanil combination in Western countries. However, literature shows that the incidence of serious AEs due to mefloquine is not higher than with chloroquine/proguanil, a classical drug combination believed to be safe with respect to AEs. It should also be borne in mind that worldwide 15-25 million individuals have already taken mefloquine chemoprophylaxis. Considering these findings, the risk of contracting malaria should be carefully weighed against that of developing AEs.
Stand-by emergency treatment (SBET) is an important option of taking antimalarial drugs based on the decision of a febrile traveler in the absence of a nearby medical facility. In particular, SBET should be prepared when travelers at high risk for malaria do not take chemoprophylaxis. Even having taken chemoprophylaxis, travelers may contract malaria due to drug resistance and therefore, SBET would become necessary. Obviously, SBET as well as chemoprophylaxis involves the use of drugs, and advantages of their use should carefully be weighed against their disadvantages.
A recent study by our group highlights inappropriate SBET among Japanese travelers with regard to the time elapsed after entering the malarious area, the accessibility to a medical facility, the medical consultation required even after SBET, and the selection of antimalarials. Thus, educating travelers about appropriate SBET use is pivotal. Rapid malaria diagnostic tests are commercially available outside Japan and have high sensitivity and specificity. However, studies have shown that inappropriate performance and interpretation of the tests are likely to occur among lay travelers especially while they are febrile.
Japanese medical personnel are not well trained in prescribing chemoprophylactic antimalarial drugs. Accordingly, future Japanese guidelines for malaria prophylaxis, in which the author has been deeply involved, could prove useful in improving malaria issues for Japanese travelers.
Decisions about preventive measures for travelers, including vaccination and malaria prophylaxis, can be influenced by various factors and can be conflicting even among specialists.
Both the development of travel medicine and the establishment of travelers' self responsibilities should be promoted in a coordinated manner.
